Description
Product Description
pHformula’s A.G.E. recovery provides multiple anti-ageing benefits. The appearance of fine lines and wrinkles can be diminished by the potent combination of Niacinamide, Pyruvic acid and Retinol. The powerful antioxidants Pycnogenol and Retinol provide protection against ageing-causing free radicals. The appearance of hyperpigmentation spots can be diminished by the synergistic action of, Niacinamide, Galactaric acid and Retinol. Glycolic acid, Pyruvic acid and Retinol assists in boosting collagen synthesis, as well as cell differentiation and skin barrier function improvement allowing optimum rejuvenation. The formulation contributes towards skin brightening and assisting in providing a more even-toned complexion.
BENEFITS
- Can diminish the appearance of fine lines and wrinkles.
- Powerful antioxidants provide protection against ageing-causing free radicals.
- Can diminish the appearance of hyperpigmentation spots.
HOW TO USE
Apply to face, neck and décolleté.
Apply 1 to 2 pumps on clean, dry skin.
Optional: follow with the recommended pHformula corrective serum.
Complete morning /evening routine with recommended pHformula moisturiser.
Caution
Keep out of reach and sight of children.
Store between 5°C and 25°C.
If irritation develops discontinue use and contact your pHformula skin specialist.
Avoid contact with eyes.
When applying at night, use instead of A.C.T.I.V.E. formula or VITA A cream.
Indications
AGEING (photo ageing, pigment changes, lentigines, telangiectasia, dull sallow appearance, keratosis, unhealthy condition of stratum corneum, wrinkles, superficial and medium expression lines)
Fitzpatrick I – VI
Active Ingredients
Retinol
Niacinamide
Pyruvic Acid
Glycolic Acid
Glycyrrhetinic acid
Pycnogenol®
Panthenol
Argan Stem Cells
Pycnogenol R
PH-DVC™
SUNBURN ALERT: This product contains a combination of active ingredients that may increase your skin’s sensitivity to sunburn. Use a sunscreen and limit sun exposure while using this product.
Size
50ml
Reviews
There are no reviews yet.